Skip to main content

Peer Review reports

From: Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin

Original Submission
17 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Jun 2021 Reviewed Reviewer Report
24 Jun 2021 Reviewed Reviewer Report - Nicola Mcmeekin
14 Sep 2021 Author responded Author comments - Mikko Pyykönen
Resubmission - Version 3
14 Sep 2021 Submitted Manuscript version 3
1 Oct 2021 Reviewed Reviewer Report
1 Oct 2021 Reviewed Reviewer Report - Nicola Mcmeekin
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
1 Oct 2021 Editorially accepted
3 Dec 2021 Article published 10.1186/s12913-021-07125-5

You can find further information about peer review here.

Back to article page